Malignant neoplasm of prostate
|
0.010 |
Biomarker
|
disease |
BEFREE |
Quantifying CCL on MRI-TBs may have a value, not previously described, to risk-stratify patients with prostate cancer before treatment.
|
30694605 |
2019 |
Bilateral cataracts (disorder)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The present study has identified a novel nonsense mutation in CRYGC associated with autosomal dominant cataracts and microcornea in a Chinese family.
|
19204787 |
2009 |
Prostate carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Quantifying CCL on MRI-TBs may have a value, not previously described, to risk-stratify patients with prostate cancer before treatment.
|
30694605 |
2019 |
Central neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We previously reported that coated cationic liposomes (CCL) targeted with a monoclonal antibody against the disialoganglioside (GD(2)) and containing c-myb antisense oligodeoxynucleotides (asODNs) resulted in a selective inhibition of the proliferation of GD(2)-positive neuroblastoma cells in vitro.
|
14555535 |
2003 |
Acute Chest Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our present findings suggest that CD, CXCL, CCL and IL genes may be used as biomarkers in the research of ACS and the immune response system may also play an important role in the pathogenesis of ACS.
|
24452942 |
2014 |
Eosinophilic disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
Interestingly, blockage of CCL-6 with a specific neutralizing antibody, restored the reconstitution ability of HSCs while exacerbating eosinophilia airway inflammation in OVA-challenged mice.
|
29327730 |
2018 |
Acanthocheilonemiasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Inflammatory and regulatory CCL and CXCL chemokine and cytokine cellular responses in patients with patent Mansonella perstans filariasis.
|
30561772 |
2019 |
B-CELL MALIGNANCY, LOW-GRADE
|
0.010 |
Biomarker
|
disease |
BEFREE |
mAbs: Monoclonal antibodies; EF2: elongation factor 2; ITs: Immunotoxins; DT: Diphtheria toxin; PE: Pseudomonas exotoxin; dgA: de-glycosylated A-chain of ricin; rGel: recombinant de-glycosylated form of gelonin; NKC: natural killer cells; HTR: human transferrin receptor; EGF: epidermal growth factor; GM-CSF: granulocyte-macrophage colony-stimulating factor; DAB389: truncated Diphtheria toxin; B-CCL: B-cell chronic lymphocytic leukemia; RCC: renal cell carcinoma; GVHD: Graft-versus-host disease; EGFR: epidermal growth factor receptor; AML: acute myeloid leukemia; Fab: fragment antigen-binding; dsFv: disulfide-stabilized fragment variable; scFv: single-chain fragment variable; B-ALL: B-lineage Acute Lymphoblastic Leukemia; Fv: fragment variable; HCL: hairy cell leukemia; IL-2R: Interleukin-2 receptor; CR: complete response; CLL: chronic lymphocytic leukemia; ATL: adult T-cell leukemia; DARPins: designed Ankyrin repeat proteins; pmol: picomolar; HAMA: human-anti mouse antibody.
|
28282218 |
2017 |
HIV-1 infection
|
0.010 |
Biomarker
|
disease |
BEFREE |
CCL-L1 binds more potently to CCR5 than any other chemokine; it inhibits HIV-1 infection in vitro, and its gene occurs in variable copy numbers, some individuals failing to produce it.
|
15096812 |
2004 |
Infectious Otitis Media
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Many CCL genes showed increased expression levels during acute OM, with CCL3 being the most upregulated, at levels 600-fold higher than the baseline.
|
28847849 |
2017 |
Childhood Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We previously reported that coated cationic liposomes (CCL) targeted with a monoclonal antibody against the disialoganglioside (GD(2)) and containing c-myb antisense oligodeoxynucleotides (asODNs) resulted in a selective inhibition of the proliferation of GD(2)-positive neuroblastoma cells in vitro.
|
14555535 |
2003 |
Malignant neoplasm of colon and/or rectum
|
0.010 |
Biomarker
|
disease |
BEFREE |
Transfection with the bi-shSTMN1-encoding expression plasmid (pbi-shSTMN1) markedly reduced CCL-247 human colorectal cancer and SK-Mel-28 melanoma cell growth in vitro (Rao et al., 2010 ).
|
21612405 |
2011 |
CATARACT, COPPOCK-LIKE
|
0.820 |
CausalMutation
|
disease |
CLINVAR |
Novel mutations in CRYGC are associated with congenital cataracts in Chinese families.
|
28298635 |
2017 |
CATARACT, COPPOCK-LIKE
|
0.820 |
CausalMutation
|
disease |
CLINVAR |
A novel nonsense mutation in CRYGC is associated with autosomal dominant congenital nuclear cataracts and microcornea.
|
19204787 |
2009 |
CATARACT 2, MULTIPLE TYPES
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Congenital cataract
|
0.360 |
CausalMutation
|
disease |
CLINVAR |
Sporadic and Familial Congenital Cataracts: Mutational Spectrum and New Diagnoses Using Next-Generation Sequencing.
|
26694549 |
2016 |
Microphthalmos
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
CATARACT 2, COPPOCK-LIKE
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
CATARACT, COPPOCK-LIKE
|
0.820 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cataract
|
0.460 |
Biomarker
|
disease |
CTD_human |
A 5-base insertion in the gammaC-crystallin gene is associated with autosomal dominant variable zonular pulverulent cataract.
|
10914683 |
2000 |
Cataract
|
0.460 |
Biomarker
|
disease |
CTD_human |
A 6-bp deletion in the Crygc gene leading to a nuclear and radial cataract in the mouse.
|
11773036 |
2002 |
Pseudoaphakia
|
0.300 |
Biomarker
|
disease |
CTD_human |
A 5-base insertion in the gammaC-crystallin gene is associated with autosomal dominant variable zonular pulverulent cataract.
|
10914683 |
2000 |
Pseudoaphakia
|
0.300 |
Biomarker
|
disease |
CTD_human |
A 6-bp deletion in the Crygc gene leading to a nuclear and radial cataract in the mouse.
|
11773036 |
2002 |
Lens Opacities
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A 6-bp deletion in the Crygc gene leading to a nuclear and radial cataract in the mouse.
|
11773036 |
2002 |
Lens Opacities
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
A 5-base insertion in the gammaC-crystallin gene is associated with autosomal dominant variable zonular pulverulent cataract.
|
10914683 |
2000 |